Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
The global landscape of metabolic medicine has been fundamentally altered by the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists. While…
Read More
Salk Institute Researchers Identify BCL6 Protein as Critical Safeguard Against Muscle Loss During Weight Loss and Aging
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic health and weight management…
Read More
Salk Institute Researchers Identify BCL6 Protein as Key Regulator for Muscle Maintenance Amid GLP-1 Weight Loss Boom
The pharmaceutical landscape of the 21st century has been fundamentally altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists.…
Read More
New Study Reveals Oral Semaglutide Outperforms Orforglipron in Weight Loss and Tolerability
Findings presented at the 33rd European Congress on Obesity in Istanbul, Turkey, on May 15th, have provided a crucial comparative…
Read More
Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option
On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…
Read More
Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Beyond the Weight Room: The Evolving Science and Therapeutic Potential of Creatine Supplementation
The scientific understanding of creatine has undergone a significant transformation, moving from its traditional reputation as a niche bodybuilding aid…
Read More
Eli Lilly Soars Past Expectations on Unabated Weight-Loss Drug Demand, Raises Full-Year Forecast
Eli Lilly and Company has once again demonstrated its formidable market power, reporting first-quarter 2026 sales that significantly surpassed analyst…
Read MoreYOU MAY HAVE MISSED
